MicroVision, Inc. Reports 2026 Annual Meeting Vote; Reverse Split Authorized

What Happened
MicroVision, Inc. filed an 8‑K reporting the results of its annual meeting of shareholders held July 10, 2026. Shareholders holding 214,190,090 shares (about 62% of voting stock) were present in person or by proxy. All seven director nominees were elected, shareholders approved issuance of shares related to senior secured convertible notes, authorized a potential reverse stock split (1‑for‑5 to 1‑for‑15) with a simultaneous reduction of authorized shares to 150 million, approved the company’s executive compensation on an advisory basis, and ratified Baker Tilly US, LLP as the company’s independent auditor for 2026.

Key Details

• Meeting date and quorum: July 10, 2026; 214,190,090 shares represented (≈62% of voting common stock).
• Directors: All seven nominees elected (Simon Biddiscombe, Robert P. Carlile, Glen W. DeVos, Jeffrey A. Herbst, Laura J. Peterson, Peter Schabert, Jada M. Smith).
• Reverse split authorization (Proposal 3): Approved — For 153,463,657; Against 57,527,379; Abstain 3,199,054. Board may implement a reverse split between 1-for-5 and 1-for-15 within one year and reduce authorized shares to 150,000,000.
• Convertible-note share issuance (Proposal 2): Approved to permit issuance of shares under senior secured convertible notes dated Feb 23, 2026 — For 104,549,049; Against 24,491,828; Abstain 2,693,080.
• Auditor ratification (Proposal 5): Baker Tilly US, LLP ratified as independent registered public accounting firm — For 191,947,924; Against 14,199,847; Abstain 8,042,319.

Why It Matters
These votes affect corporate governance and capital structure. The reverse stock split authorization gives the board discretion to reduce share count (which can affect per‑share metrics and share price behavior) and is often pursued for listing or market‑perception reasons; any split would be implemented at the board’s timing within one year. Approval to issue shares tied to the February 2026 convertible notes clears a regulatory hurdle (including Nasdaq compliance) to convert those notes into common stock. Director re‑elections maintain board continuity, and auditor ratification finalizes the company’s independent accounting oversight for 2026.